(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) recommends low-dose aspirin for reducing the risk for preeclampsia among those at high risk. This recommendation forms the basis of the final recommendation statement ...
Sep 28, 2021
0
2
A community-led suicide prevention trial in country South Australia has helped reduce the stigma around depression, increased community awareness, and provided helpful guidance to community members when responding to people ...
Sep 10, 2021
0
2
U.S. researchers—who only a half century ago largely excluded women from clinical trials—now ensure they comprise half the study participants in National Institutes of Health-funded research.
Jun 21, 2021
0
5
A University of Alberta virology lab has uncovered how an oral antiviral drug works to attack the SARS-CoV-2 virus, in findings published May 10 in the Journal of Biological Chemistry.
May 11, 2021
0
5
While a number of topical products designed to reduce the occurrence of sexually transmitted infections have been tested with largely disappointing results, researchers at Boston University School of Medicine (BUSM), Alpert ...
Feb 3, 2021
0
0
(HealthDay)—It will be tempting for folks to think they can resume a 'normal' life after they've received the two-dose course of the COVID-19 vaccine.
Dec 16, 2020
0
13
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) recommends behavioral counseling interventions aimed at promoting healthy weight gain during pregnancy. This recommendation forms the basis of a draft recommendation ...
Dec 9, 2020
0
1
Early unblinding of the of long-acting cabotegravir (CAB LA) is a milestone for prevention of HIV among women in sub Saharan Africa.
Nov 10, 2020
0
6
With nearly half of the world's population at risk for life-threatening malaria infections, University of Maryland School of Medicine (UMSOM) researchers and their colleagues identified an important public health measure ...
Oct 23, 2020
0
1
Colchicine reduces the risk of major cardiovascular events in patients with chronic coronary disease, according to results of the LoDoCo2 trial presented in a Hot Line session today at ESC Congress 2020.
Aug 31, 2020
0
5
